Stephen J.H. Dobbin
-
- Chemotherapy-induced cardiotoxicity and mitigation 5
- Cardiovascular Function and Risk Factors 4
- Cardiac Valve Diseases and Treatments 2
- Cardiac pacing and defibrillation studies 2
- Heart Failure Treatment and Management 2
-
- Cancer Treatment and Pharmacology 2
-
- Cardiac Imaging and Diagnostics 3
-
- Chemotherapy-induced organ toxicity mitigation 2
- Co-authors
- Ninian N. LangMark C. PetrieRhian M. TouyzJ. D. EvansRachel C. MylesEmanuele Di AngelantonioStephen PettitPeter Willeit
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Stephen J.H. Dobbin
11 papers receiving 281 citations
Peers
Comparison fields: 5 of 59
- Cardiology and Cardiovascular Medicine 173
- Oncology 83
- Pulmonary and Respiratory Medicine 58
- Internal Medicine 6
- Cancer Research 23
Countries citing papers authored by Stephen J.H. Dobbin
This map shows the geographic impact of Stephen J.H. Dobbin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen J.H. Dobbin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen J.H. Dobbin more than expected).
Fields of papers citing papers by Stephen J.H. Dobbin
This network shows the impact of papers produced by Stephen J.H. Dobbin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen J.H. Dobbin. The network helps show where Stephen J.H. Dobbin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Stephen J.H. Dobbin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 8 | |
| 5 | 2022 | 5 | |
| 6 | 2022 | 8 | |
| 7 | 2021 | 59 | |
| 8 | 2021 | 75 | |
| 9 | 2020 | 7 | |
| 10 | 2018 | 60 | |
| 11 | 2018 | 51 | |
| 12 | 2018 | 3 | |
| 13 | 2017 | 8 | |
| 14 | 2015 | 1 |
About Stephen J.H. Dobbin
Stephen J.H. Dobbin is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Pathology and Forensic Medicine, having authored 14 papers that have together received 285 indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (5 papers), Cardiovascular Function and Risk Factors (4 papers), Cardiac Imaging and Diagnostics (3 papers), Cardiac Valve Diseases and Treatments (2 papers), Cardiac pacing and defibrillation studies (2 papers), Heart Failure Treatment and Management (2 papers), Cancer Treatment and Pharmacology (2 papers) and Chemotherapy-induced organ toxicity mitigation (2 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (173 citations), Oncology (83 citations) and Pulmonary and Respiratory Medicine (58 citations). Stephen J.H. Dobbin has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Ninian N. Lang, Mark C. Petrie, Rhian M. Touyz, J. D. Evans, Rachel C. Myles, Emanuele Di Angelantonio, Stephen Pettit, Peter Willeit, Alan C. Cameron and Robert J. Jones. Their work appears in journals such as Circulation Research, Cardiovascular Research and Heart.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.